Overview
Details
Chat
Gilead Sciences, Inc. (GILD.US) Q1 2022 Earnings Conference Call
Live streaming time: 29/04/2022 06:00
Gilead Sciences, Inc. (Gilead Sciences, Inc.) is a biopharmaceutical company engaged in the research, development, and commercialization of drugs in the field of unmet medical needs. The company's main business areas include human immunodeficiency virus, acquired immunodeficiency syndrome, liver disease, hematology, oncology, inflammation, and respiratory system diseases. The company's Q1 2022 fiscal year report is expected to be released on April 28, 2022 (Eastern Time).
Live Assistant
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.